>PROKKA_00001 Deoxyuridine 5'-triphosphate nucleotidohydrolase
LPQRGSKISAGYDFSTPIEVTIQPNESKLIWTDVKAYMQEGEVLIIDVRSSIGVKKGLML
SNTIGVIDADYYQNKDNDGNIGISLRNMSDKPVTLEAGERIAQGIFIPFLVADNGNTDKI
RQGGIGSTGTK*
>PROKKA_00002 hypothetical protein
MTNTKIQLPSDMTTEEYNILMEICKDIPCKSSKDKKDIKILHNTINQIYIDSVINECWN*
>PROKKA_00003 DNA adenine methylase
MYKALRQGWIPPTIISKEEYEYIKNHKNEKPYLTGFVGFGCSYSGKWFGGYAKNKSQRNY
CLNAHNSIMKKINSLYNAEFKCCDYKELKPKGSIIYCDPPYKGTTQYDKSIVGKFNTEEF
WDIMRKWSKNNKVFISEYEAPDDFKCIWSKETKLDIRDKNNMKQKRVEKLFTYKNQ*
>PROKKA_00004 hypothetical protein
MKYIYNPLVDTFNNMYKTYKPLIDLAEHNKAITKLINIPISKNKLQRYDILLRQIKPLKD
RYTCYHYTPLNVKIININLNKIDLNCLQNCVSKCKFRHLQGYNNKLNKNKATVNIKHITY
IDEHSINKILHQVVNKLDSEEERKLFLWVISLIEDSIKENQSKTT*
>PROKKA_00005 transcriptional regulator BotR, P-21
MNDLFYAIENLKHDNQHFDFIEMSLKKYIEKTSKKYNLYYDYYNDILYHLWKELIEINLK
NFNSELDLRKYISTSIKRYCINICKKKNRDKKIIYNLEATYKKLEAVNVYSLYCEDFEFL
DLISILNYKERQIIYMKFFECRKDNEIARRLHLSRQSIYKIRIKSLKKLYPIVMQLVNI*
>PROKKA_00006 Hemagglutinin components HA-22/23/53 precursor
MSLSIKELYYTKDKSINNVNLADGNYVVNRGDGWILSRQNQNLGGNISNNGCTAIVGDLR
IRETATPYYYPTASFNEEYIRNNVQNVFANFTEASEIPIGFEFSKTAPSNKSLYMYLQYT
YIRYEIIKVLQNTVIERAVLYVPSLGYVKSIEFNSGEQIDKNFYFTSEDKCILNEKFIYK
KIAETTTAKESNDSNNTTNLNTSQTILPYPNGLYVINKGDGYMRTNDKDLIGTLLIETNT
SGSIIQPRLRNTTRPLFNTSNPTLFSQEYTEARLNDAFNIQLFNTSTALFKFVEEAPDNK
NISMKAYNTYEKYELINYQDGNIADKAEYYLPSLGKCEVSDAPSPQAPVVETPVDQDGFI
QTGPNENIIVGVINPSENIEEISTPIPDDYTYNIPTSIQNNACYVLFTVNTTGVYKINAQ
NNLPPLIIYESIGSDNMNIQSNTLSNNNIKAINYITGTDSANAESYLIVSLIKNKNYYIR
IPQISSSTTNQLIFKRELGNISDLANSTVNILDNLNTSGTHYYTRQSPDVGNYISYQLTI
PGDFNNIASSIFSFRTRNNQGIGTLYRLTESINGYNLITIKNYSDLLNNVEPISLLNGAT
YIFRVKVTELNNYNIIFDAYRNS*
>PROKKA_00007 HA 17 kDa subunit
MSSERTFLPNGNYKIKSLFSNSLYLTYSSGALSFSNTSSLDNQKWKLEYISSSNGFRFSN
VAESNKYLAYNDYGFIYLSSSSNNSLWNPIKIAINSYIICTLSIVNVTDYAWTIYDNNNN
ITNQPILNLPNFDINNSSQILKLEKL*
>PROKKA_00008 hypothetical protein
MSQTNANDLRNNEVFFISPSNSTNKVLDKISQSEVKLWSKNLGSNQKWRLIYDTNKQAYK
IKVMDNTSLILTWDAPLSSVSVKTDTNTNNQYWYLLQDYISRNVILRNYMNPNLVLQYNT
DDTLIVSTQTSSNNQFFKFSNCIYEALNNRNCKLQTQLNSDRFLSKNLNSQIIVLWQWFD
SSRQKWLIEYNETKSAYTLKCQENNRYLTWIQNSNNYVETYQSTDSLIQYWNINYLDNDA
SKYILYNLQDTNRVLDVYNSQIANGTNVIVDSYHGNTNQQWIINLI*
>PROKKA_00009 Botulinum neurotoxin type E precursor
MDINDDLNINSPVDNKNVVIVRARKTNTFFKAFKVAPNIWIAPERYYGEPLDIAEEYKLD
GGIYDSNFLSQDSERENFLQAIITLLKRINNTISGKQLLSLISTAIPFPYGYVGGGYSSP
NIFTFGKTPKSNKKLNSLVTSTIPFPFGGYRETNYIESPNNKDFYASNIVIFGPGSNIVE
NNVICYKKNDAENGMGTMAEILFQPLLTYKYNKFYIDPAMELTKCLIKSLYFLYGIKPSD
GLVVPYRLRTELDNKQFSQLNIIDLLISGGVDLEFINTNPYWFTNSYFSNSIKMFEKYKN
IYETEIEGNNAIGNDIKLRLRQKFQNSVQDIWNLNLNYFSKEFNSIIPDRFSNALKHFYR
KQYYTMDYTDNYNINGFVNGQINTKLPLSDKNTNIISKPEKVVNLVNENNISLMKSNIYG
DGLKGTTEDFYSTYKIPYNEEYEYRFNDSDNFPLNNISIEEVDSIPEIIDINPYKDNSDN
LVFTQITSMTEEVTTHTALPINYLQAQITTNENFTLSSDFSKVVSSKDKSLVYSFLDNLM
SYLETIKNDGPIDTDKKYYLWLKEVFKNYSFDINLTQEIDSSCGINEVVIWFGKALNILN
TSNSFVEEYQNSGPISLISKKDNLSEPNIEIDDIPDSLLGLSFKDLNNKLYEIYSKNIVY
FKKIYFNFLDQWWTEYYSQYFELICMAKQSILAQESLVKQIIQNKFTDLSKASIPPDTLK
LIKETTEKTFIDLSKESQISMNRVDNFLNKASICVFVEDIYPKFISYMEKYINNINIKTR
EFIQRCTNINDNEKSILINSYTFKTIDFKFLDIQGIKNFFNSQVEQVMKEMLSPYQLLLF
ATRGPNSNIIEDISGKNTLIQYTESVELVYGVNGESLYLKSPNETVEFSNNFFTNGLTNN
FTICFWLRFTGKDDDKTRLIGNKVNNCGWEIYFEDNGLVFEIIDSNGNQESVYLSNVINN
NWYYISISVDRSKDQLLIFINDKNVANVSIEQILNIYSTNVISLVNKNNSIYVEELSVLD
KTVTSEEVIRNYFSYLDNSYIRDSSKSLLEYNKNYQLYNYVFPKTSLYEVNDNNKSYLSL
KNTDGINIPSVKFKLINIDESKGYVQKWDECIICVSDGTEKYLDISSENNRIQLVSSKDN
AKKITVNTDLFRPDCITFSYNDKYFSLSLRDGDYNWMICNDNNKVPKGAHLWILES*
>PROKKA_00010 Botulinum neurotoxin type C1 precursor
VDIRKLGDVSIMPITINNFNYSDPVDNKNILYLDTHLNTLANEPEKAFRIIGNIWVIPDR
FSRDSNPNLNKPPRVTSPKSGYYDPNYLSTDSEKDTFLKEIIKLFKRINSREIGEELIYR
LATDIPFPGNNNTPINTFDFDVDFNSVDVKTRQGNNWVKTGSINPSVIITGPRENIIDPE
TSTFKLTNNTFAAQEGFGALSIISISPRFMLTYSNATNNVGEGRFSKSEFCMDPILILMH
ELNHAMHNLYGIAIPNDQRISSVTSNIFYSQYKVKLEYAEIYAFGGPTIDLIPKSARKYF
EEKALDYYRSIAKRLNSITTANPSSFNKYIGEYKQKLIRKYRFVVESSGEVAVDRNKFAE
LYKELTQIFTEFNYAKIYNVQNRKIYLSNVYTPVTANILDDNVYDIQNGFNIPKSNLNVL
FMGQNLSRNPALRKVNPENMLYLFTKFCHKAIDGRSLYNKTLDCRELLVKNTDLPFIGDI
SDIKTDIFLSKDINEETEVIDYPDNVSVDQVILSKNTSEHGQLDLLYPIIEGESQVLPGE
NQVFYDNRTQNVDYLNSYYYLESQKLSDNVEDFTFTTSIEEALDNSGKVYTYFPKLADKV
NTGVQGGLFLMWANDVVEDFTTNILRKDTLDKISDVSAIIPYIGPALNISNSVRRGNFTE
AFAVTGVTILLEAFQEFTIPALGAFVIYSKVQERNEIIKTIDNCLEQRIKRWKDSYEWMI
GTWLSRITTQFNNISYQMYDSLNYQADAIKDKIDLEYKKYSGSDKENIKSQVENLKNSLD
IKISEAMNNINKFIRECSVTYLFKNMLPKVIDELNKFDLKTKTELINLIDSHNIILVGEV
DRLKAKVNESFENTIPFNIFSYTNNSLLKDIINEYFNSINDSKILSLQNKKNALVDTSGY
NAEVRLEGDVQVNTIYTNDFKLSSSGDKIIVNLNNNILYSAIYENSSVSFWIKISKDLTN
SHNEYTIINSIKQNSGWKLCIRNGNIEWILQDINRKYKSLIFDYSESLSHTGYTNKWFFV
TITNNIMGYMKLYINGELKQSERIEDLNEVKLDKTIVFGIDENIDENQMLWIRDFNIFSK
ELSNEDINIVYEGQILRNVIKDYWGNPLKFDTEYYIINDNYIDRYIAPKSNILVLVQYPD
RSKLYTGNPITIKSVSDKNPYSRILNGDNIMFHMLYNSGKYMIIRDTDTIYAIEGRECSK
NCVYALKLQSNLGNYGIGIFSIKNIVSQNKYCSQIFSSFMKNTMLLADIYKPWRFSFENA
YTPVAVTNYETKLLSTSSFWKFISRDPGWVE*
>PROKKA_00011 hypothetical protein
VIEEQQLNKDLKKVKEKFIKALVRTLNEENENRVYDGKKPLDVCFMVSIIDKQLHQYKDF
LEDLSNGYTFNGYEEDESGYSNGKISLFIEKHIEDKESNLWASTYKQDYWYSIEFKYDTK
DWGYCQCEPNDKGYNEEHDCCGETCDWDAPSFAITKEYYLGTCSWDGFQRDYWEYEKMFK
SKEENKNKRVEDEIKERRKQEIKIQIEMLSKELLSLGS*
>PROKKA_00012 hypothetical protein
MFYLKGMMKVNNNINVTRLITYYNTNCKHYWIKTRVGLLKNKNKIIKN*
>PROKKA_00013 hypothetical protein
MKIKKESRIPGYDKFELIQYVSSTLLAISYLPQIIKILCTHNVTSQSLWFWIILSIGLVG
IDINAFHIMKSTKKKAFFIGQTVNALLGITILIQVLVYM*
>PROKKA_00014 Nucleoside 2-deoxyribosyltransferase
MKLNNFNNKLKEFISKQGLSDLGLKYNFNNEVKVYLASGFLFENLGQLGLEILADLCENM
NLKYYLPQHAEFNDKTTTDFMITNKMIADGDDRELRTCQFSLAHTQSPMDDGVCGEIGRF
KTMCEYEPDKYWGVISWVDDIRLGTIPDPKQASFNNQTCYLNQYIIGEIENSLGCYETLD
KCFEKMYKIYLDKKNKQ*
>PROKKA_00015 hypothetical protein
LQLDSLNQNETIVKIVNKNSDWYGLYGIIDYINDECAYVFCISKPTYHYKVTKDNIDDIE
IIRLKNCKNRLLSSMGI*
>PROKKA_00016 Thymidine kinase
MKESIKYMAQLYYRYGVLNSAKSANLIMAVHNYDKKNRRVIVLKPKIDTRSKPNIVESRV
GISHSCIDFDKNENLFELVNTLNSKDIIHAVFVEEVQFITKEQAKQLHKIVHKLNIPTLG
YGLKNTYIDGELFEGSKAMLFYADKIEEIKDVCEYCDKKATQNLRVVNGQPVYSGETIQI
GNVNSDLEEYYVPVCGHHYYHPELKK*
>PROKKA_00017 hypothetical protein
MSFSDYCKQDKLEKSIAYICNCEYKYFLNKANVVGVGCGYKVKNGFYTNQLCIQVFVSRK
FAQNQLSSNDMVPLMYKGIQTDVKETGHFTACSLTEKIRPTLGGYIIGNEYDTVHSGTLG
CLVTDGKNLFILSNNHVLASTNFAPLGNKIIQPSYAFGGDFKTDVVAILSKFIPIKFEGI
IKAPSNYADCAIAKVINKSLVSPRIAFVGIPQEPIVPRLDQSIKKVGYSTELTSGIIIGI
NATAEVHSATTEEKFLFKEQIVTTNIGSSGDSGALLLDPSNHTLGLLMSGCSSRNICNPI
KYILKELDVRIVTS*
>PROKKA_00018 DNA gyrase subunit A
MADLKRLKGSERVRKRVSVMMGSDDIRGCQHTLFEIVSNSIDRHRKGFGNYIKVIKYEDL
SYTIIDHADGLPMDWNDKENAYNWDLALKVLYAGDNYDANSTALGINGLGLCSSQYASEY
MKVISYKDGKKYTVKCKKGRPIDKETEEFICGDDDNLFTKEQGERVLLVESNTESKTGTY
IHYKPDLEVFTNIDISIDWINDKLDKQSMVNKGLKIEVYDEKEDKLYTHYYESGIKDYIK
TISDDNNFSDVIYFTDKGKGRDKVDKPEYDYNYEIALVFNNEINKLEYYHNSSELLQGGS
TADAINLAFTYAINEYAKDNNLFNKNESKIKFTDIQDSLICVISSFSTMTSYANQTKLSI
DNKFIKDFTNQSLKEKLKLYFIENKLEADRVVNQILINKRANDKAEKTKLNIKKTLQTKS
NFDDTDNFYACTSNDKSITELYLAEGSSAQGSIVMGRNSKFQACYHVGGKMLSLLKADFE
KIFKNKVVRELFQYLGCGIEIKSKHNKDLNTFDENNLNYSKIILATDQDTDAFQIRCLML
TAIHRLAPTLIKHGYVYIAESPLYEITTADKVYHAYTEEEKITILEKLSKKGIKYDKPER
NKGLGEVDSDIIAETMMNPKTRKITRVTVQDVEKMANTFELWLGDEVKPRKEVITSNFDY
IEHFDNEQEKDIVKVLNENYLPYAIEVIKERAIISIDGFKPAHRKLLWTLHESNLYNKRT
KSAHIVGSNMSLNVHGDGSIYETLVRMAQKDTLLYPYVNGKGNFGQHTSKSLQNAHMRYT
EAGASNINKEFFHGINKNAVDFVPNFDGEKEEPILLPTTFPNVLVNANKGIAVGMASATP
SFNLKEVCDLTIAYIKDTNIVVSDYLLCPDFATGGFIVRDVDKLNQIYETGQGSVTLRAK
YGVKDNEIIVTEIPYTTNRESIVKDIKTLCRESKDNIIRNITNVIDSTDRKGMSITIKIK
KNTNIELLMEKLYANTKLQDSYSLNMNIVCLDKIPRVLSIKRILDEWLKFRRMCISRVSN
YDKKDKEHKLHLLNAFKIILTDIDALVHITRNAIDDDDMIKQLQLYFKIDQEQAEYVSNI
KLKKLNKNNIIEITEQQITALQQEISDLKNIQNDETRINNIIIQQLQNIRDKYKIPRKTE
IINVEDIPSVTLEDIKIEDFNPTLVLTEQQYIKKNRVFSQSQKLKDDDKILQFHQCNNKD
DLLLFTNKGNVLIRKVYELDEHKPSTYGDFLPNLLGEHLENDEEVIYISTTKDYKGSVVS
VFENGYIARTDLQTYKPKQNRQIPMSAYNTDSKIVSIQLITNDTDILLVSQEGKSLIINT
SQIRPTKSRNTQGVSGMKIDIETNKIIASIIGVTVDDNFNIETEKGKSKFIMLNDVAPNG
KESMTEYLKGNRNTQGNFIYNTRQKNDKVIKLTKQEN*
